Pharmaceutical exporters operating out of India’s Jawaharlal Nehru Port Trust (JNCH) are reporting significant customs delays that are disrupting the flow of time-sensitive cargo.
The logistical bottlenecks at the Nhava Sheva port have raised concerns among shippers regarding the handling of temperature-controlled consignments, which require strict adherence to cold-chain protocols to maintain product integrity.
The industry body Pharmexcil has formally escalated the issue, seeking detailed explanations from JNCH officials regarding the operational challenges causing the hold-ups.
The association is specifically pressing for clarity on how the port is managing the specialized requirements of pharmaceutical shipments, which often face higher scrutiny and complex documentation processes compared to general cargo.
For traders and logistics providers, these delays represent a tangible supply-chain risk.
Prolonged dwell times at the port can lead to increased warehousing costs, potential spoilage of sensitive goods, and missed delivery windows for critical medical supplies.